Mingming Sun
Tongji University(CN)Nanchang University(CN)Capital Medical University(CN)Harbin Institute of Technology(CN)Nankai University(CN)Beijing Normal University(CN)Wenzhou Medical University(CN)China Tobacco(CN)China Rehabilitation Research Center(CN)Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University(CN)Jinan Central Hospital(CN)Kingmed Diagnostics(CN)Chinese Institute for Brain Research(CN)Shanghai East Hospital(CN)Shanghai Tenth People's Hospital(CN)Shandong First Medical University(CN)State Key Laboratory of Medicinal Chemical BiologyHenan Normal University(CN)Capital Normal University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Inflammatory Bowel Disease, RNA Research and Splicing, Gut microbiota and health, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases(2016)1,046 cited
- → Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis(2018)646 cited
- → GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3(2018)497 cited
- → Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43(2016)467 cited
- → Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis(2019)208 cited
- → miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD(2015)156 cited